In addition to variations of BRCA1/2, CDH1, PTEN and TP53 that are highly associated with BC risk, variations in ATM, BARD1, CHEK2, PALB2 and RAD51D were also associated with moderate or high BC risk. Here, BARD1 is linked to breast cancer.